Tang Capital Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Tang Capital Management’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$342K	Hold	100,000	–	–	0.02%	41
2026 Q1	$358K	Hold	100,000	–	–	0.02%	51
2025 Q4	$351K	Sell	100,000 -750,000	-88%	-$2.57M	0.02%	72
2025 Q3	$2.77M	Hold	850,000	–	–	0.11%	114
2025 Q2	$2.08M	Hold	850,000	–	–	0.11%	116
2025 Q1	$5.67M	Buy	850,000 +100,000	+13%	+$988K	0.31%	72
2024 Q4	$9.43M	Hold	750,000	–	–	0.62%	46
2024 Q3	$13.9M	Hold	750,000	–	–	0.99%	31
2024 Q2	$16.1M	Buy	750,000 +90,000	+14%	+$2.07M	1.64%	17
2024 Q1	$17.8M	Buy	660,000 +410,000	+164%	+$11.6M	1.85%	13
2023 Q4	$7.49M	Buy	250,000 +100,000	+67%	+$2.21M	0.69%	39
2023 Q3	$3.07M	Buy	+150,000	New	+$2.73M	0.43%	61
2022 Q4	–	Sell	-1,265,900	Closed	-$20.2M	–	102
2022 Q3	$20.2M	Hold	1,265,900	–	–	2.48%	11
2022 Q2	$17.4M	Hold	1,265,900	–	–	2.64%	12
2022 Q1	$20.1M	Sell	1,265,900 -1,265,900	-50%	-$21.9M	4.02%	7
2021 Q4	$55.3M	Hold	2,531,800	–	–	11.12%	3
2021 Q3	$75.7M	Hold	2,531,800	–	–	15.71%	2
2021 Q2	$112M	Hold	2,531,800	–	–	22.32%	2
2021 Q1	$112M	Sell	2,531,800 -433,685	-15%	-$23.8M	31.61%	1
2020 Q4	$163M	Hold	2,965,485	–	–	24.83%	2
2020 Q3	$67.8M	Hold	2,965,485	–	–	12.27%	2
2020 Q2	$62.1M	Hold	2,965,485	–	–	6.03%	3
2020 Q1	$41.4M	Hold	2,965,485	–	–	5.81%	3
2019 Q4	$67.5M	Hold	2,965,485	–	–	8.06%	3
2019 Q3	$34.5M	Hold	2,965,485	–	–	5.91%	4
2019 Q2	$44.5M	Hold	2,965,485	–	–	6.01%	4
2019 Q1	$52M	Hold	2,965,485	–	–	9.58%	3
2018 Q4	$43.9M	Hold	2,965,485	–	–	10.08%	3
2018 Q3	$73M	Hold	2,965,485	–	–	11.92%	4
2018 Q2	$58.2M	Hold	2,965,485	–	–	7.38%	4
2018 Q1	$55.6M	Buy	+2,965,485	New	+$48.4M	8.17%	4

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Tang Capital Management's RCKT Position: Q2 2026 in Review

Tang Capital Management held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 100,000 shares worth $342K. The position accounts for 0.02% of the portfolio, ranked #41.

Tang Capital Management first reported a position in RCKT in Q1 2018 and has held it in 31 quarters since. The position peaked at $163M in Q4 2020. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

Tang Capital Management held 100,000 shares of Rocket Pharmaceuticals worth $342K as of Q2 2026.
Tang Capital Management left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
Rocket Pharmaceuticals made up 0.02% of Tang Capital Management's portfolio in Q2 2026, its #41 holding.
Tang Capital Management first reported a position in Rocket Pharmaceuticals in Q1 2018 and has held it in 31 quarters since.
Tang Capital Management's Rocket Pharmaceuticals position peaked at $163M in Q4 2020.
180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Tang Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.